Synthesized novel isatin based thiosemicarbazone compounds.
Structure was confirmed by spectroscopic techniques and single crystal XRD.
In silico screening of anti-inflammatory and anti-tuberculosis properties.
Thiosemicarbazone derivatives showed anti-oxidant and anti-haemolytic properties.